MedTrace Logo

3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors

NCT01470365 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-05-08

No results posted yet for this study

Summary

This phase I trial studies the side effects and best dose of 3-dimensional conformal radiation therapy (CRT) or intensity-modulated radiation therapy (IMRT) in treating patients with recurrent tumors. Radiation therapy (RT) uses high energy x rays to kill tumor cells. Palliative radiation therapy may help patients with recurrent tumors live more comfortably.

Conditions

  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

PROCEDURE

quality-of-life assessment

Ancillary studies

RADIATION

intensity-modulated radiation therapy

Undergo IMRT

RADIATION

3-dimensional conformal radiation therapy

Undergo 3-dimensional CRT

Sponsors & Collaborators

  • Fox Chase Cancer Center

    lead OTHER

Principal Investigators

  • C-M Charlie Ma, PhD · Fox Chase Cancer Center

  • Josphua Meyer, MD · Fox Chase Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-03
Primary Completion
2015-08-31
Completion
2019-02-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01470365 on ClinicalTrials.gov